What is the catalog number for Pyridostigmine-d6 Bromide?

The catalog number for Pyridostigmine-d6 Bromide is CS-O-06898.

What sizes are available for Pyridostigmine-d6 Bromide?

Pyridostigmine-d6 Bromide is available in the following size(s): 1 Each.

Is Pyridostigmine-d6 Bromide in stock?

Pyridostigmine-d6 Bromide is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Pyridostigmine-d6 Bromide?

The safety data sheet for Pyridostigmine-d6 Bromide is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-O-06898.

Pyridostigmine-d6 Bromide

Pyridostigmine-d6 Bromide is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Pyridostigmine. The product is supplied by Clearsynth under CAT No. CS-O-06898. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

"Labelled Pyridostigmine Bromide . Cholinergic, used in the treatment of myasthenia gravis, and is a pre-exposure antidote to chemical warfare agents.; Labeled Pyridostigmine, intended for use as an internal standard for the quantification of Pyridostigmine by GC- or LC-mass spectrometry."

CAS Number

2375858-08-3

Synonyms

Pyridostigmine-d6 Bromide

Molecular Formula

C 9 H 7 D 6 BrN 2 O 2

Molecular Weight

267.15

Additionnal Information

Pyridostigmine-d6 Bromide is supplied with detailed characterization data compliant with regulatory guideline. Pyridostigmine-d6 Bromide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Pyridostigmine.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

"Labelled Pyridostigmine Bromide . Cholinergic, used in the treatment of myasthenia gravis, and is a pre-exposure antidote to chemical warfare agents.; Labeled Pyridostigmine, intended for use as an internal standard for the quantification of Pyridostigmine by GC- or LC-mass spectrometry."